CDKN2A and breast carcinoma: Treatment with the senolytic drugs Dasatinib + Quercetin (DQ) prevented or reduced the increased expression of p16Ink4a, Mmp13, and Il6 (Fig. 4d), supporting a direct link between the changes in gene expression and the cellular senescence induced by breast cancer cells.